US EditionBone Biologics Files Patent Application for Bone Regeneration Technology – Ortho Spine News
Summary by Ortho Spine News | Your Trusted Voice for Medical Device Industry Ortho News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Bone Biologics Files Patent Application for Bone Regeneration Technology – Ortho Spine News
BURLINGTON, Mass., June 27, 2025 -(BUSINESS WIRE)- Bone Biologics Corporation (“Bone Biologics” or the “Company) (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces the filing of a patent application with the United States Patent and Trademark Office (USPTO) for its novel NELL-1 protein. The patent application is directed to compositions of rhNELL-1 polypeptide and uses thereof for treating bone condit
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
